Literature DB >> 15182360

The effect of HAMP domains on class IIIb adenylyl cyclases from Mycobacterium tuberculosis.

Jürgen U Linder1, Arne Hammer, Joachim E Schultz.   

Abstract

The genes Rv1318c, Rv1319c, Rv1320c and Rv3645 of Mycobacterium tuberculosis are predicted to code for four out of 15 adenylyl cyclases in this pathogen. The proteins consist of a membrane anchor, a HAMP region and a class IIIb adenylyl cyclase catalytic domain. Expression and purification of the isolated catalytic domains yielded adenylyl cyclase activity for all four recombinant proteins. Expression of the HAMP region fused to the catalytic domain increased activity in Rv3645 21-fold and slightly reduced activity in Rv1319c by 70%, demonstrating isoform-specific effects of the HAMP domains. Point mutations were generated to remove predicted hydrophobic protein surfaces in the HAMP domains. The mutations further stimulated activity in Rv3645 eight-fold, whereas the effect on Rv1319c was marginal. Thus HAMP domains can act directly as modulators of adenylyl cyclase activity. The modulatory properties of the HAMP domains were confirmed by swapping them between Rv1319c and Rv3645. The data indicate that in the mycobacterial adenylyl cyclases the HAMP domains do not display a uniform regulatory input but instead each form a distinct signaling unit with its adjoining catalytic domain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15182360     DOI: 10.1111/j.1432-1033.2004.04172.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  HAMP domain-mediated signal transduction probed with a mycobacterial adenylyl cyclase as a reporter.

Authors:  Laura García Mondéjar; Andrei Lupas; Anita Schultz; Joachim E Schultz
Journal:  J Biol Chem       Date:  2011-11-17       Impact factor: 5.157

Review 2.  Cyclic AMP signalling in mycobacteria: redirecting the conversation with a common currency.

Authors:  Guangchun Bai; Gwendowlyn S Knapp; Kathleen A McDonough
Journal:  Cell Microbiol       Date:  2010-12-28       Impact factor: 3.715

3.  The linker region in receptor guanylyl cyclases is a key regulatory module: mutational analysis of guanylyl cyclase C.

Authors:  Sayanti Saha; Kabir Hassan Biswas; Chandana Kondapalli; Nishitha Isloor; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

4.  Identification of cyclic AMP-regulated genes in Mycobacterium tuberculosis complex bacteria under low-oxygen conditions.

Authors:  Michaela A Gazdik; Kathleen A McDonough
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

Review 5.  The myriad roles of cyclic AMP in microbial pathogens: from signal to sword.

Authors:  Kathleen A McDonough; Ana Rodriguez
Journal:  Nat Rev Microbiol       Date:  2011-11-14       Impact factor: 60.633

6.  Characterization of phylogenetically distant members of the adenylate cyclase family from mycobacteria: Rv1647 from Mycobacterium tuberculosis and its orthologue ML1399 from M. leprae.

Authors:  Avinash R Shenoy; Nandini P Sreenath; Mohana Mahalingam; Sandhya S Visweswariah
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

7.  Origin of asymmetry in adenylyl cyclases: structures of Mycobacterium tuberculosis Rv1900c.

Authors:  Sangita C Sinha; Martina Wetterer; Stephen R Sprang; Joachim E Schultz; Jürgen U Linder
Journal:  EMBO J       Date:  2005-01-27       Impact factor: 11.598

Review 8.  cGMP production in bacteria.

Authors:  Jürgen U Linder
Journal:  Mol Cell Biochem       Date:  2009-11-27       Impact factor: 3.396

9.  Transmembrane signaling in chimeras of the Escherichia coli aspartate and serine chemotaxis receptors and bacterial class III adenylyl cyclases.

Authors:  Kajal Kanchan; Jürgen Linder; Karin Winkler; Klaus Hantke; Anita Schultz; Joachim E Schultz
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

10.  Significant role for ladC in initiation of Legionella pneumophila infection.

Authors:  Hayley J Newton; Fiona M Sansom; Jenny Dao; Christel Cazalet; Holger Bruggemann; Christiane Albert-Weissenberger; Carmen Buchrieser; Nicholas P Cianciotto; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.